OR13-3 Effects of Iron Isomaltoside versus Ferric Carboxymaltose on Hormonal Control of Phosphate Homeostasis: The PHOSPHARE-IDA04/05 Randomized Controlled Trials

Iron isomaltoside (IIM) and ferric carboxymaltose (FCM) are newer intravenous iron preparations that can be administered in high-doses to rapidly correct iron deficiency anemia (IDA). FCM can cause hypophosphatemia due to fibroblast growth factor 23 (FGF23) mediated renal phosphate wasting, which ha...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Endocr Soc
Autori principali: Wolf, Myles, Rubin, Janet, Achebe, Maureen, Econs, Michael, Peacock, Munro, Imel, Erik, Thomsen, Lars, Carpenter, Thomas, Weber, Thomas, Zoller, Heinz
Natura: Artigo
Lingua:Inglês
Pubblicazione: Endocrine Society 2019
Soggetti:
Bone and Mineral Metabolism
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6554827/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-OR13-3
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi